Victor Ankoma‐Sey

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C

M. Rodríguez‐Torres, Lennox J. Jeffers, Muhammad Y. Sheikh et al. · New England Journal of Medicine · 2009 · 183 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Randomised clinical trial: faecal microbiota transplantation for recurrent <i>Clostridum difficile</i> infection – fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy

Zhi‐Dong Jiang, Nadim J. Ajami, J. F. Petrosino et al. · Alimentary Pharmacology & Therapeutics · 2017 · 183 citations

Life Sciences, Infectious Diseases, Microbiology +17

Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells

Victor Ankoma‐Sey, Yun Wang, Zhihao Dai · Hepatology · 2000 · 179 citations

Medicine, Biochemistry, Pathobiology +17